Thomas Edison

Edison Investment Research Limited: Avon Protection (AVON): Refocused Protection set to resume growth

Retrieved on: 
Friday, January 21, 2022 - 7:02am
Research, Armour, EBITDA, DCF, CBRN, Financial services, Thomas Edison

Future growth rates are diminished by the exit but remain healthy in the further focused core of Respiratory and Head Protection.

Key Points: 
  • Future growth rates are diminished by the exit but remain healthy in the further focused core of Respiratory and Head Protection.
  • Management needs to restore investor confidence as it continues with its growth strategy, in order to regain the historical premium rating to its UK defence peers.
  • In this note, we reset our forecasts and valuation to reflect the revised shape of the business.
  • About Edison: Edison is a leading research and investor relations consultancy, connecting listed companies to the widest pool of global investors.

SIGA Technologies to Participate in Edison Group’s Global Healthcare “Open House” Virtual Conference from January 25-27th, 2022

Retrieved on: 
Tuesday, January 18, 2022 - 12:30pm
Vaccination, Research, Vaccine, House, EMA, Office of Inspector General, U.S. Department of Health and Human Services, IV, NASDAQ, GLOBE, Human services, Assistant, BARDA, Development, Smallpox, Project Bioshield Act, U.S. Department of Commerce Office of Security, Infection, Monkeypox, Heart, Vaccinia, Asiapac Books, Cowpox, FDA, Biomedical Advanced Research and Development Authority, SIGA Technologies, Thomas Edison

NEW YORK, Jan. 18, 2022 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, announced today that it will be participating in Edison Groups Open House Event, scheduled to take place virtually this month.

Key Points: 
  • NEW YORK, Jan. 18, 2022 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, announced today that it will be participating in Edison Groups Open House Event, scheduled to take place virtually this month.
  • SIGA Chief Executive Officer, Phil Gomez, will be presenting and will be available for 1x1 meetings.
  • Presentation information: The company presentation will be available on demand on www.edisongroup.com beginning at 7am ET on Wednesday, January 26th.
  • Edison Advisors leverages its core research platform to provide differentiated services including investor relations and strategic consulting.

OpGen to Participate in Edison Group’s Global Healthcare “Open House” Virtual Conference from January 25-27th, 2022

Retrieved on: 
Tuesday, January 18, 2022 - 12:30pm
Association, Research, Technology, Drug discovery, Health, Nadine Opgen-Rhein, House, Precision medicine, NGS, Informatics, GLOBE, Solution, Female gendering of AI technologies, Nasdaq, Infection, Company, London Stock Exchange, Pharmaceutical industry, Thomas Edison, MD

The three-day event, in association with London Stock Exchange, global law firm Taylor Wessing and OpenExchange, will take place between 25th-27th January, focusing on 33 companies.

Key Points: 
  • The three-day event, in association with London Stock Exchange, global law firm Taylor Wessing and OpenExchange, will take place between 25th-27th January, focusing on 33 companies.
  • Day one will feature businesses within pharmaceuticals & drug discovery, day two focuses on AI & technology in healthcare, while businesses adopting new approaches to hard-to-solve problems will round off the event.
  • Presentation information: The company presentation will be available on demand on www.edisongroup.com beginning at 7am ET on Thursday, January 27th.
  • Edisons leading research and investor relations consultancy connects listed companies to the widest pool of global investors.

Evogene to Participate in Edison Group's Global Healthcare "Open House" Virtual Conference from January 25-27th, 2022

Retrieved on: 
Wednesday, January 19, 2022 - 12:00pm
Research, Computation, Computational biology, Biology, CPB, NASDAQ, Open House, Health, Castor oil, Artificial intelligence, Heart, TASE, Company, Agriculture, Therapy, Asiapac Books, AG, Pharmaceutical industry, Thomas Edison

For more information on the event and details on how to register, please see below.

Key Points: 
  • For more information on the event and details on how to register, please see below.
  • Presentation information:The company presentation will be available on demand on http://www.edisongroup.com beginning at 7am ET on Thursday, January 27th.
  • Edison is an investment research, investor relations and consulting firm, with offices in North America, Europe, the Middle East and AsiaPac.
  • Edison Advisors leverages its core research platform to provide differentiated services including investor relations and strategic consulting.

Aditxt, Inc. to Participate in Edison Group’s Global Healthcare “Open House” Virtual Conference From January 25th-27th, 2022

Retrieved on: 
Friday, January 14, 2022 - 2:00pm
Biotechnology, Pharmaceutical, Health, Medical Devices, Association, Research, Technology, Health, House, COVID-19, London, Female gendering of AI technologies, Nasdaq, Company, Allergy, London Stock Exchange, Immune system, Drug discovery, Degenerative disease, Vaccine, Thomas Edison

Aditxt, Inc. (Aditxt or the Company) (Nasdaq: ADTX) announced today it is participating in Edison Groups Open House Event, scheduled to take place virtually this month.

Key Points: 
  • Aditxt, Inc. (Aditxt or the Company) (Nasdaq: ADTX) announced today it is participating in Edison Groups Open House Event, scheduled to take place virtually this month.
  • The three-day event, in association with the London Stock Exchange, global law firm Taylor Wessing, and OpenExchange, will take place between January 25th-27th, focusing on 33 companies.
  • Day one will feature businesses within pharmaceuticals & drug discovery, day two focuses on AI & technology in healthcare, while businesses adopting new approaches to hard-to-solve problems will round off the event.
  • Presentation information: The company presentation will be available on demand on www.edisongroup.com beginning at 7am ET on Wednesday, January 26th.

Edison Investment Research Limited: Trackwise Designs (TWD): Connection under demanding conditions

Retrieved on: 
Friday, January 14, 2022 - 8:02am
Research, Technology, EV, Growth, Innovation, EBITDA, IHT, EVS, Electric power industry, Thomas Edison

Trackwise Designs has developed a proprietary, proven technology, IHT, for manufacturing extremely long, flexible circuits that can replace conventional wiring harnesses.

Key Points: 
  • Trackwise Designs has developed a proprietary, proven technology, IHT, for manufacturing extremely long, flexible circuits that can replace conventional wiring harnesses.
  • Since listing in July 2018, Trackwise has invested substantially in capacity, acquiring Stevenage Circuits in March 2020 and a new site in Stonehouse in April 2021.
  • The new site is scheduled to commence production in Q122 as Trackwise starts deliveries on an order worth up to 54m from a UK EV manufacturer.
  • About Edison: Edison is a leading research and investor relations consultancy, connecting listed companies to the widest pool of global investors.

Edison Investment Research Limited: RTW Venture Fund (RTW) - Initiation: 'One-stop shop' for biotech lifecycle investment

Retrieved on: 
Wednesday, January 12, 2022 - 9:02am
Investment, RTW, Research, Health, Initial public offering, Financial services, Thomas Edison

Edison Investment Research Limited: RTW Venture Fund (RTW) - Initiation: 'One-stop shop' for biotech lifecycle investment

Key Points: 
  • Edison Investment Research Limited: RTW Venture Fund (RTW) - Initiation: 'One-stop shop' for biotech lifecycle investment
    RTW Venture Fund (RTW) - Initiation: 'One-stop shop' for biotech lifecycle investment
    RTW Venture Fund (RTWVF) is managed by healthcare specialist RTW Investments (RTW), which was founded in 2009 by Dr Roderick Wong.
  • RTWVF provides investors with broad exposure to the global biotech (c 85% of the fund) and medtech (c 15%) sectors.
  • Since inception in late October 2019, the fund has outpaced the performance of both small- and large-cap biotech indices.
  • About Edison: Edison is a leading research and investor relations consultancy, connecting listed companies to the widest pool of global investors.

Organigram Reports First Quarter Fiscal 2022 Results

Retrieved on: 
Tuesday, January 11, 2022 - 11:00am
Agriculture, Natural Resources, Alternative Medicine, General Health, Health, Specialty, Food, Beverage, Retail, Calendar, Breeding, Thomas Edison, Research, EBITDA, International, BAT, Centre for Excellence in Mining Innovation, ...Continued, Enzyme, Biolab, Science, EIC, CBD, Growth, Health Canada, Cannabis, Center, SG, Edible, Leadership, Quality assurance, Automation, Jolt, COE, Cannabinoid, Acquisition, Process Systems Design and Control Laboratory, Fiscal, THC, Director, General Administration of Press and Publication, Company, ASP, Genetics, Advertising, Investment, Food, Stock, PDC, Organizational chart, Strategic Investment Group, Renewable energy, Pharmaceutical industry, Mobile phone, Security (finance), Bank, Drug, Fine chemical, Agriculture, Spice, Cryptocurrency, Laurentian

Q1 Fiscal 2022 adjusted gross margin was $5.5 million, or 18% of net revenue, compared to $1.9 million, or 10%, in Q1 Fiscal 2021.

Key Points: 
  • Q1 Fiscal 2022 adjusted gross margin was $5.5 million, or 18% of net revenue, compared to $1.9 million, or 10%, in Q1 Fiscal 2021.
  • Revenues in Fiscal 2022 to date including a shipment to Canndoc that was in excess of $3.0 million, and purchase orders received from customers, support the Companys expectation of revenue growth from Fiscal 2021 to Fiscal 2022.
  • Q2 Fiscal 2022 SG&A is expected to increase slightly from Q1 Fiscal 2022, due to the addition of Laurentian.
  • Shipments to Canndoc Ltd., which resumed in Q1 Fiscal 2022, are expected to continue during Fiscal 2022.

Edison Investment Research Limited: Agronomics (ANIC) Initiation - At the forefront of a new agrarian revolution

Retrieved on: 
Tuesday, January 11, 2022 - 8:02am
Meat, IFRS, NAV, Research, Sale, ANIC, Seafood, Investment, Awareness, Financial services, Thomas Edison

Agronomics (ANIC) invests in companies producing environmentally friendly alternatives to traditionally produced meat, dairy, seafood, materials and other agricultural products.

Key Points: 
  • Agronomics (ANIC) invests in companies producing environmentally friendly alternatives to traditionally produced meat, dairy, seafood, materials and other agricultural products.
  • Click here to view the full report or here to sign up to receive research as it is published.
  • About Edison: Edison is a leading research and investor relations consultancy, connecting listed companies to the widest pool of global investors.
  • Having been the first in-market 17 years ago, Edison now has more than 100 analysts covering every economic sector.

Inspira Health Appoints Lydia Stockman, RN, MHA, FACHE, as Chief Administrative Officer

Retrieved on: 
Monday, January 3, 2022 - 3:09pm
Managed Care, Hospitals, Health, Inspira Health Network, Growth, Safety, Cooper University Hospital, GE Healthcare, Lean Six Sigma, Health administration, Seton Hall University, Technology, Investment, Lockheed Martin, Thomas Edison State University, Service, ICU, HPI, RN, Mortality, National Association Medical Staff Services, Health, Leadership, Senior, Physician, CAO, High reliability organization, Multimedia, Knowledge, Hospital, United Nations Development Programme, Robert Wood Johnson University Hospital, Thomas Edison, Advocacy, Directory, Stockman, Mentorship, Patient, Strategic planning, Patient satisfaction, American College, MHA, Patient safety, COO, Environment, Rehabilitation, Nursing, Stroke, Management, Medicine, Science, Atlantic Ocean

Inspira Health today announced the appointment of Lydia Stockman, RN, MHA, FACHE, to Chief Administrative Officer for Inspira Medical Centers Mullica Hill and Woodbury, effective January 10.

Key Points: 
  • Inspira Health today announced the appointment of Lydia Stockman, RN, MHA, FACHE, to Chief Administrative Officer for Inspira Medical Centers Mullica Hill and Woodbury, effective January 10.
  • This experience, coupled with working in a high reliability organization, uniquely positions Lydia to innately understand the future of Inspira Health as outlined in our new strategic plan.
  • I look forward to partnering with her to advance health care in our community.
  • For more information about Inspira Health, visit www.InspiraHealthNetwork.org or call 1-800-INSPIRA.